Market revenue in 2024 | USD 79.2 million |
Market revenue in 2030 | USD 93.8 million |
Growth rate | 2.9% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.17% in 2024. Horizon Databook has segmented the UAE hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The HAI diagnostics market in the UAE has presence of prominent players such as Siemens Healthineers, Roche, and local firms such as Julphar. These markets prioritize innovation, with global companies introducing advanced molecular and automation-based diagnostics.
Partnerships with government health agencies are common strategies to increase market penetration. Recent developments include Roche's regional expansion and increased adoption of AI-integrated diagnostics.
In the UAE and Saudi Arabia, regulatory bodies such as the Ministry of Health (MOH) oversee diagnostic approvals. Regulations prioritize international quality standards, ensuring the adoption of cutting-edge solutions.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UAE hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account